过氧化物酶增殖物激活受体γ(PPARγ)激动剂罗格列酮在血管新生和血管通透性变化中的作用-生物医学工程专业论文.docxVIP

过氧化物酶增殖物激活受体γ(PPARγ)激动剂罗格列酮在血管新生和血管通透性变化中的作用-生物医学工程专业论文.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
重庆大学硕士学位 重庆大学硕士学位论文 英文摘要 PAGE PAGE VI ABSTRACT Pathological angiogenesis is a critical event associated with formation and progression of tumor, atherosclerosis and diabetic retinopathy. On the one hand, newborn microvessels promote the development of these diseases by supplementing oxgen and nutrients. On the other hand, these microvessels exhibit defective features that are closely associated with the increase of microvascular permeability. The structural and functional abnormality, commonly characterized by absence of cell junctions and base membrane as well as peripheral cells, promotes vascular permeability and results in macromolecules extravasation. Highly permeabible vessels allow infiltration of tumor cells and inflammatory cells as well as production and local accumulation of angiogenic factors, ultimately exacerbating vessel-related diseases. Therefore, angiogenesis inhibition is proposed as a promising strategy to limit these vessel-related diseases. As the effective drug in antagonizing type II diabetes, peroxisome proliferator-activated receptor γ (PPARγ) ligand rosiglitazone is also a significant modulator of angiogenic processes and may prove to be a potential therapeutic strategy in correcting angiogenesis-related diseases. However, studies on PPARγ and the ligand rosiglitazone yielded contradictory findings with regard to its role in angiogenesis. Additionally, treatment with rosiglitazone often causes side effects like edema that are related to increased vascular permeability. Thus, the aim of this study is to identify the angiogenic and vascular permeability response to PPARγ activation by its ligand rosiglitazone. Related knowledge could pave way to safe treatment of angiogenesis-related diseases with rosiglitazone. Resusts are shown below. Chapter one: the regulatory role and mechanism of PPARγ activation by its ligand rosiglitazone in angiogenesis ① In vivo zebrafish angiogenesis model, ex vivo rat aortic ring model and in vitro human umbi

您可能关注的文档

文档评论(0)

1234554321 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档